Quotations

Famous Quotations

Sometimes it is difficult to be motivated and inspired to write a review, a persuasive formless essay, an article of reflexive investigation, etc. Plus, it can be difficult to find the right words that will better describe your ideas. DedicatedWriters.com is your top destination, since it provides students with an updated database of more than 150.000 quotations and proverbs of famous inventors, sportsmen, philosophers, artists, celebrities, businessmen, and the authors who certainly enriched and strengthen the world. This is perfect to become inspired and write book reports, essays, movie reviews, research papers, etc.

Try out our free search option and stay tuned.

Browse Authors

(Click a letter to view the authors)
A B C D E F G H I J K L M N O
P
Q R S T U V W X Y Z

Pete Nicholas Quotes

«This transaction provides a unique opportunity to advance our strategy to further diversify and to expand the growth markets we serve.»
Author: Pete Nicholas
«By any objective measure, our offer is clearly superior to Johnson & Johnson's.»
Author: Pete Nicholas
«The shareholders of both Guidant and Boston Scientific will benefit from the significant upside potential of the combined company, which will be strongly positioned in a wide range of medical markets and be supported by a more diversified base of revenues and earnings.»
Author: Pete Nicholas
«Our amended offer addresses all of the outstanding issues raised by Guidant's board.»
Author: Pete Nicholas
«Our amended offer addresses all of the outstanding issues raised by Guidant's Board. We have increased the value of our offer, satisfied any perceived antitrust concerns and provided shareholders increased certainty of value by agreeing to pay interest on the $73 share price if the transaction is not closed by the end of the first quarter. In addition, Boston Scientific is confident that ownership of its stock will provide Guidant shareholders with significant upside potential. We strongly encourage the Guidant Board to act in the best interests of Guidant shareholders by declaring our $73 per share offer superior to the revised $67.92 per share transaction with Johnson & Johnson.»
Author: Pete Nicholas
«Our amended offer addresses all of the outstanding issues raised by Guidant's Board. We strongly encourage the Guidant Board to act in the best interests of Guidant shareholders by declaring our $73 per share offer superior to the revised $67.92 per share transaction with Johnson & Johnson.»
Author: Pete Nicholas
«Our amended offer addresses all of the outstanding issues raised by Guidant's Board. We have increased the value of our offer, satisfied any perceived antitrust concerns and provided shareholders increased certainty of value by agreeing to pay interest on the $73 share price if the transaction is not closed by the end of the first quarter.»
Author: Pete Nicholas
«We are providing Guidant shareholders with certainty of completion, significant upside potential and substantially more value today than the Johnson & Johnson transaction.»
Author: Pete Nicholas
«Our $80 per share offer for Guidant is compelling. We are providing Guidant shareholders with certainty of completion, significant upside potential and substantially more value today than the Johnson & Johnson transaction. By any objective measure, our offer is clearly superior to Johnson & Johnson's.»
Author: Pete Nicholas
«We are providing the shareholders of Guidant with certainty of completion, significant upside potential and substantially more value today than the Johnson & Johnson transaction. By any objective measure, our offer is clearly superior to Johnson & Johnson's.»
Author: Pete Nicholas